MyAverix Finance
HK · Healthcare
Beijing Biostar Pharms Co Ltd (2563)
Biotechnology
Beijing Biostar Pharms Co Ltd (2563) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $1.63B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2563
Beijing Biostar Pharms Co Ltd (2563) — FAQ
What is Beijing Biostar Pharms Co Ltd's market cap?
Beijing Biostar Pharms Co Ltd (2563) has a reported market cap of $1.63B (data as of 2026-05-21).
What is 2563's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Biostar Pharms Co Ltd (2563) is 18.00 (data as of 2026-05-21).
Does Beijing Biostar Pharms Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Biostar Pharms Co Ltd (2563). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Biostar Pharms Co Ltd in?
Beijing Biostar Pharms Co Ltd (2563) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2563 listed on?
2563 is listed on HK.
What is Beijing Biostar Pharms Co Ltd's net margin?
Beijing Biostar Pharms Co Ltd (2563) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.